A phase I/II study for the tolerance, safety, cell kinetics and efficiency of immunotherapy in patients With stage III/IV colorectal cancer

ABSTRACT: Interventions: Group 1:CAR-T;Group 2:combined immunotherapy Primary outcome(s): Tumor imaging;Cytokine IL-6;Cytokine TNF-a;CRP;Copy numbers of CART in vivo Study Design: Non randomized control

DISEASE(S): Colorectal Cancer

PROVIDER: 2685830 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR